ACIP Recommends RSV Vaccine for All Adults After Previously Limiting Eligibility to Those 60 and Older

The Advisory Committee on Immunization Practices (ACIP) voted Wednesday to recommend expanding the eligibility for the respiratory syncytial virus (RSV) vaccine to include a broader age range of adults. The committee’s decision now advises that adults can get the RSV vaccine. Previously, the ACIP recommended the RSV vaccine for adults aged 60 and older. Now adults are able to get the RSV vaccine to help combat the virus.

Newsflash | Powered by GeneOnline AI
Date: April 16, 2025

Related posts:

FDA Approves Pfizer/BioNTech’s COVID-19 Vaccine for 5- to 11-Year-Olds Generic Drug Stability Testing: ICH Guidelines Ensure Consistent Framework Across Regions Need for Meticulous Quality Control in Generic Drug Production, From R&D to Manufacturing Generic Drug Pricing Strategies & U.S. Prices Rise 300% in 10 Years

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後